Remove Food and Drug Administration Remove Recruitment Remove Specialization
article thumbnail

THINK Surgical’s TMINI System Receives FDA Special 510(k) Clearance for Use With Additional Implants

Legacy MEDSearch

an innovator in the field of orthopedic surgical robots, today announced that its TMINI Miniature Robotic System has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with implants from three additional implant manufacturers. THINK Surgical, Inc.,

article thumbnail

Cardio Flow, Inc., Announces FDA Clearance for FreedomFlow® Peripheral Guidewire, and their First Commercial Case Completed in U.S.

Legacy MEDSearch

Food and Drug Administration (FDA) clearance for the company’s FreedomFlow® Peripheral Guidewire. Co-founded by Dr. Jihad Mustapha and Dr. Fadi Saab, ACV Centers has a special concentration on treating peripheral artery disease and the complications of critical limb ischemia. Cardio Flow, Inc., The post Cardio Flow, Inc.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lazurite is Recognized in the 2022 Medical Device Network Excellence Awards & Rankings for its ArthroFree™ System

Legacy MEDSearch

Food and Drug Administration market clearance for the ArthroFree System. This was followed by additional partnerships with Hospital for Special Surgery (HSS) in New York, University Hospitals of Cleveland, and LG Electronics USA.”. “We The company hit an important milestone in March 2022 when it received U.S.

article thumbnail

FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis

Legacy MEDSearch

Food and Drug Administration (FDA) granted marketing authorization of the MISHA Knee System, an implantable shock absorber (ISA) for the knee. Chief, Hip and Knee Division of Sports Medicine Institute, Hospital for Special Surgery in New York. Contact us to discuss partnering with Legacy MedSearch on your position.

article thumbnail

SpectraWAVE Secures 510(k) Clearance of HyperVue™ Intravascular Imaging System

Legacy MEDSearch

a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today announced Food and Drug Administration (FDA) 510(k) clearance of their flagship intravascular imaging system, HyperVue. SpectraWAVE, Inc.,

article thumbnail

Rare Disease Day 2024: Advocating for Awareness and Support

PM360

Given that less than 10% of rare diseases currently have an available treatment approved by the United States Food and Drug Administration (FDA) , advocating for the speedy development of novel drugs and therapies is a crucial step in improving the quality of life for those affected. What is a Rare Disease?

article thumbnail

Clinical Research News: Social Determinants Of Health Data Help Identify Sites For Trials

Clarify Health

End users of Clarify Trials are typically study team members involved in the design of studies and strategies for recruiting participants, says Drouin. That said, you can identify the places [facilities or the clinicians] where those kinds of individuals were seen” that can then be approached to help recruit them.